DUDERSTADT, Germany, Sept. 15, 2017 /PRNewswire/ — Prof. Hans Georg Nader’s youngest daughter, Georgia, will in future be representing the family on Ottobock’s supervisory board, which is currently being formed. Otto Bock HealthCare GmbH, based in the German state of Lower Saxony, is undergoing the conversion to an SE & Co. KGaA. Georgia Nader will therefore also be enlisted to the executive board of Otto Bock Holding GmbH & Co. KG.
Following nearly three decades in his role as CEO at Otto Bock HealthCare GmbH, Prof. Hans Georg Nader (56) will be assuming the leadership of the supervisory board of the future Ottobock SE & Co. KGaA as chairman of the board. Dr Oliver Scheel (49) will take over the role of CEO on 15 January 2018.
The appointment of Dr Scheel, a long-time partner and managing director at consulting company A.T. Kearney and head of their pharma, medical technology and healthcare department who possesses extensive expertise in the subject of transformation management, represents the first time in Ottobock’s history that a manager from outside the family has taken the helm of the German-based “hidden champion” and global market leader in the field of technical orthopaedics.
Longstanding CFO Harry Wertz (60) will exclusively continue his role as CEO with the Otto Bock Holding GmbH & CoKG.
The head of the Nader Family Office, Stefan Hirsch (45), was also enlisted to the executive board of Otto Bock Holding GmbH & Co. KG as part of the developments within the company.
Head of Investor Relations / Corporate Communications Mark C. Schneider Phone: +49(0)30-398-206-222 / mobile: +49(0)151-146-591-35 Email: MarkC.Schneider@ottobock.de
-Walker Leads the Sourcing Pillar of Young Living’s Seed to Seal Program-
LEHI, Utah, Aug. 18, 2017 /PRNewswire/ —Young Living Essential Oils, the world leader in essential oils, today announced that it has promoted Lauren Walker to the role of Chief Supply Officer. In her time with Young Living, she and her team have further implemented rigorous sourcing standards while also streamlining manufacturing, warehousing and fulfillment operations.
“Lauren embraces Young Living’s passion for being stewards of the earth and has been a driving force in ensuring that the sourcing, manufacturing and shipping components of our business all operate under that mindset,” said Jared Turner, Young Living Chief Operating Officer. “Her experience and expertise in project management, manufacturing, and supply chain gained throughout her career has been a great addition to our strong executive team.”
Walker leads the sourcing pillar of Young Living’s Seed to Seal program (Sourcing, Science and Standards), that governs how we obtain our products — whether from our corporate-owned farms, partner farms, or Seed to Seal-certified supplier. The sourcing pillar is also a major part of how we verify, through internal and third-party tracking, that the superior essential oils and premium ingredients in our products such as foods, skin care, and supplements were produced and manufactured according to industry best practices and our own high standards.
“We have an obligation to provide our customers with the highest quality products and the best customer experience, and we do that by having effective processes in place,” said Walker. “I’m proud that our team has assessed the whole supply chain of an oil and refined or established processes that help us provide the best products and services to our customers.”
Throughout her three-decade career with high-profile international companies, Walker has established herself as a leader and an innovator in streamlining global systems. After completing her engineering degree, she worked for Xerox as an engineer, followed by 10 years with Procter & Gamble in supply chain, manufacturing/technical operations, and quality. She also worked for seven years with Johnson & Johnson as a plant manager and as Program Manager of their Oral Care franchise. Prior to joining Young Living in 2016, she was Vice President of Manufacturing at Amway, where she was responsible for manufacturing across all product lines: nutrition, home care, personal care, beauty care, durable goods, and paper products.
In addition to her extensive experience, Walker has been a keynote speaker for American Manufacturing Strategies Summit and Front End Innovations Conference, is a Lean Six Sigma Project Champion in Manufacturing, and is Green Belt Certified. She holds a degree in engineering from Union College in New York. Lauren currently serves on the Board of Directors for the Salt Lake Chamber.
About Young Living Essential Oils Young Living Essential Oils, LC, is the world leader in essential oils, with a strict Seed to Seal® process that produces pure essential oil products for every individual, family, and lifestyle. This process ensures that all products are genuine, free of synthetic chemicals, and pure. This commitment stems from the company’s more than 20 years of stewardship toward the earth and its people. For more information, visit YoungLiving.com.
VANCOUVER, British Columbia, Aug. 11, 2017 /PRNewswire/ — Ondine Biomedical Inc. is pleased to announce that its President and Chief Technology Officer, Dr. Nicolas Loebel, was the 2017 recipient of the International Photodynamic Association’s CLINICAL PDT RESEARCH EXCELLENCE AWARD. The award was presented at the World Congress held in Coimbra, Portugal. The Coimbra World Congress was the 16th conference held by the International Photodynamic Association, marking 32 years of this global meeting. The IPA World Congresses, held every two years, are the leading PDT meetings bringing together members of the global photodynamic community in order to advance scientific and clinical research relating to photodiagnosis and photodynamic therapies.
“I am delighted to see that Dr. Loebel was duly recognized by his peers for his clinical advancement of antimicrobial photodynamic therapy and track record of research excellence. This IPA recognition is well deserved.” stated Professor Michael Wilson, inventor of antimicrobial photodynamic therapy. Professor Wilson is Emeritus Professor of Microbiology at the Eastman Dental Institute in the Faculty of Medical Services of University College London (UCL). Professor Wilson was the first to successfully treat complex biofilm infections using antimicrobial PDT, demonstrating the potency of this technology against multidrug-resistant pathogens.
Ondine Biomedical Inc. is a Canadian medical device company developing and commercializing antimicrobial photodynamic therapies to treat and prevent multidrug resistant infections. Dr. Nicolas Loebel and his team at Ondine Research Laboratories have developed 5 antimicrobial photodynamic products, including Periowave™ (oral infections), Sinuwave™ (sinus infections), MRSAid™ (nasal decolonization), Steriwave™ (skin infections) and Exelume™ (VAP reduction), positioning Ondine as the global leader in Photodisinfection based therapies. More than 300,000 patients have been treated with Ondine’s technologies globally, demonstrating excellent clinical outcomes and safety profiles. For more information, please visit: www.ondinebio.com
HOUSTON, July 26, 2017 /PRNewswire/ — OrthoAccel® Technologies, Inc. announces that its board of directors has named David Josza, an orthodontic and dental industry senior executive with more than 25 years of experience, as CEO effective August 1, 2017. A privately owned medical technology start-up, OrthoAccel recently launched its third-generation vibratory orthodontic device AcceleDent® Optima™ that enables orthodontists to achieve more predictable outcomes. AcceleDent Optima is an FDA-cleared, Class II medical device that is clinically shown in randomized control trials to speed up orthodontic treatment by as much as 50 percent while reducing discomfort by up to 71 percent during treatment.
“OrthoAccel is a market leader in accelerated orthodontic technology and I am delighted to lead the company’s next phase of growth and innovation,” said Josza. “This is an exciting stage in OrthoAccel’s trajectory and, based on the feedback of orthodontists and patients who have experienced the new AcceleDent Optima, there is significant opportunity for growth ahead for this best-in-class treatment technology.”
Josza most recently served as corporate vice president and general manager for Zimmer Biomet Dental, a leading global manufacturer of musculoskeletal devices. He joined Zimmer in 2015 when the company acquired his previous firm, Biomet, Inc., and Josza was tapped to lead the complex acquisition integration. Among his accomplishments, he successfully implemented synergistic cost-saving initiatives and cross-selling opportunities that yielded significant profit increases and growth.
Prior to the acquisition, Josza had a 14-year career at Biomet 3i, a global implant and oral reconstructive supplier, most recently serving as vice president of the Americas. As a member of the executive board, he was responsible for developing and delivering the company’s annual strategic plan.
Additional accomplishments at Biomet included developing and leading a variety of significant revenue growth initiatives, including capturing the market leader position in Latin America. Another key accomplishment was the commercialization of a new digital product line, with a specialized sales team and a technical service support function that grew incremental revenue by $2 million in its first year.
In addition to his leadership roles at Zimmer and Biomet, Josza’s in-depth experience includes previous business development, strategic planning and management responsibilities at Henry Schein, Inc. and Stryker Corporation.
“We are excited to welcome David and recognize that his in-depth experience in dental and medical industries, combined with his many successes as a strategist and business developer, provide an excellent leadership platform for his role at OrthoAccel Technologies,” said Brian R. Smith, chairman of OrthoAccel’s board of directors and managing director of S3Ventures.
The leader in accelerated orthodontics, OrthoAccel has received numerous business and medical design awards that reflect the company’s success in commercializing its patented SoftPulse Technology® for clinical application. AcceleDent has been recognized as the preferred accelerated orthodontic treatment solution by orthodontists participating in surveys conducted by industry journals Orthotown and the Journal of Clinical Orthodontics.
For more information about OrthoAccel and the company’s innovative orthodontic solutions, visit AcceleDent.com.
About OrthoAccel® Technologies, Inc. OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company’s innovations is AcceleDent® Optima™, an FDA-cleared, Class II medical device that employs patented SoftPulse Technology® that is demonstrated to speed up bone remodeling. These safe and gentle vibrations accelerate tooth movement by as much as 50 percent and reduce discomfort associated with orthodontic treatment by up to 71 percent. Leading orthodontists from around the world report increased mechanical efficiency with orthodontic appliances and improved predictability of clinical outcomes with AcceleDent. OrthoAccel, the Leader in Accelerated Orthodontics, is ranked on Deloitte’s 2016 Technology Fast 500 as one of the fastest growing companies in North America. OrthoAccel is based in Houston, Texas and maintains a global presence through its EMEA office in Essen, Germany. To learn more about OrthoAccel’s focus on improving the journey to healthy, beautiful smiles, visit AcceleDent.com.
PHILADELPHIA, July 6, 2017 /PRNewswire/ — Clarivate Analytics, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Chris Veator joined the company as President of its MarkMonitor business. Veator will lead the global MarkMonitor team from its San Francisco office.
Chris Veator joins Clarivate Analytics to lead its MarkMonitor business
MarkMonitor is the global leader in online brand protection, and provides advanced technology and expertise that protects the revenues and reputations of the world’s foremost brands. It leads the industry in providing domain management, anti-piracy and anti-fraud solutions to more than half of the Fortune 100.
“With the company’s focus on innovation, I’m excited to join at a time when Clarivate is making a major investment in new technology and analytics that is already in production with 100 MarkMonitor customers,” said Veator.
Prior to this role, Veator was President of Metrostudy, a Hanley Wood company, where he oversaw the rapid growth of the real estate and construction information business. Prior to that, he was Executive Vice President and Global Head of Intellectual Property Services at Thomson Reuters. Veator has also held senior executive roles at CPA Global, OpenText and was the founder and CEO of Artesia Technologies – a Digital Asset Management software company.
“Chris is a high-energy executive and an exciting addition to our team as we focus on building Clarivate Analytics and accelerating its growth,” said Jay Nadler, CEO of Clarivate Analytics. “He has had success both as an entrepreneur and as an “intrapreneur”, driving growth of new initiatives within a corporate setting. I look forward to what Chris will bring to the MarkMonitor business.”
Clarivate Analytics
Clarivate™ Analytics accelerates the pace of innovation by providing trusted insights and analytics to customers around the world, enabling them to discover, protect and commercialize new ideas faster. Formerly the Intellectual Property and Science business of Thomson Reuters, we own and operate a collection of leading subscription-based businesses focused on scientific and academic research, patent analytics and regulatory standards, pharmaceutical and biotech intelligence, trademark protection, domain brand protection and intellectual property management. Clarivate™ Analytics is now an independent company with over 4,000 employees, operating in more than 100 countries and owns well‐known brands that include Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor® and Techstreet™, among others. For more information, please visit clarivate.com.
